Skip to main content
Dan Longo, MD, Oncology, Brookline, MA

Dan L. Longo MD


Professor of Medicine, Brigham and Women's Hospital

Join to View Full Profile
  • 111 Cypress StBrookline, MA 02445

  • Phone+1 857-307-0896

  • Fax+1 410-350-3979

Dr. Longo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1977
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 1975

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1976 - 2027
  • MD State Medical License
    MD State Medical License 1977 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • SARS-CoV-2 Vaccination — an Ounce (Actually, Much Less) of Prevention  
    Eric J Rubin, Dan L Longo, The New England Journal of Medicine
  • Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint Blockade  
    R Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature
  • Plateletpheresis-Associated Lymphopenia in Frequent Platelet Donors  
    Michael B Brenner, John M Gansner, A Helena Jonsson, Dan L Longo, Jason M Schenkel, Deepak A Rao, Richard M Kaufman, Nancy Berliner, Duane R Wesemann, Blood

Abstracts/Posters

  • Macrophage Checkpoint Blockade in Cancer — Back to the Future
    Dan Longo, MD, The New England Journal of Medicine, Orlando, FL, 12/8/2019

Press Mentions

  • Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma
    Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin LymphomaNovember 14th, 2024
  • Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin’s Lymphoma
    Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin’s LymphomaOctober 16th, 2024
  • Immunotherapy Improves Survival in People with Advanced Hodgkin Lymphoma, Study Shows
    Immunotherapy Improves Survival in People with Advanced Hodgkin Lymphoma, Study ShowsOctober 16th, 2024

Grant Support

  • The Reveal StudyNational Institute On Aging2009
  • Structure-Function Relationship Of NFKB P65National Institute On Aging2009
  • Shaping The Preimmune B Cell RepertoireNational Institute On Aging2009
  • Role Of Hyperplasia Suppressor Gene (HSG) In Cell Growth.National Institute On Aging2009
  • Rapamycin-Sensitive Pathway Of T Cell ActivationNational Institute On Aging2009

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: